AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?The Motley Fool • 06/22/26
Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout OfferThe Motley Fool • 06/22/26
This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie24/7 Wall Street • 06/16/26
Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a BetZacks Investment Research • 06/16/26
Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck AppearancePRNewsWire • 06/16/26